Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1273-1277

  Kauntz, Henriette ^a,b   Bousserouel, Souad ^a,b   Gossé, Francine ^a,b   Raul, Francis ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b IRCAD   (France)

Author keywords

Colorectal cancer; Combination therapy; DNMT inhibitors; HDAC inhibitors; Silibinin

Indexed keywords

DNA METHYLTRANSFERASE; FLAVONOLIGNAN; HISTONE DEACETYLASE; SILIBININ; TRICHOSTATIN A; VORINOSTAT;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CANCER GROWTH; CELL DEATH; COLON ADENOCARCINOMA; COLORIMETRY; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FLOW CYTOMETRY; NONHUMAN;

EID: 84874407846     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1190     Document Type: Article

References (22)

1. Lu Q, Qiu X, Hu N, Wen H, Su Y and Richardson BC: Epigenetics, disease, and therapeutic interventions. Ageing Res Rev 5: 449-467, 2006.
2. Song SH, Han SW and Bang YJ: Epigenetic-based therapies in cancer: progress to date. Drugs 71: 2391-2403, 2011.
3. Carew JS, Giles FJ and Nawrocki ST: Histone deacetylaseinhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 269: 7-17, 2008.
4. Mariadason JM: HDACs and HDAC inhibitors in colon cancer. Epigenetics 3: 28-37, 2008.
5. Ashktorab H, Belgrave K, Hosseinkhah F, Brim H, Nouraie M, Takkikto M, Hewitt S, Lee EL, Dashwood RH and Smoot D: Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma. Dig Dis Sci 54: 2109-2117, 2009.
6. Emanuele S, Lauricella M and Tesoriere G: Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). Int J Oncol 33: 637-646, 2008.
7. Wagner JM, Hackanson B, Lübbert M and Jung M: Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics 1: 117-136, 2010.
8. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428, 2002.
9. Migliore L, Migheli F, Spisni R and Coppedè F: Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011: 792362, 2011.
10. Rius M and Lyko F: Epigenetic cancer therapy: rationales, targets and drugs. Oncogene 31: 4257-4265, 2012.
11. Cameron EE, Bachman KE, Myöhänen S, Herman JG and Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107, 1999.
12. Thakur VS, Gupta K and Gupta S: Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis 33: 377-384, 2012.
13. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W and Yang CS: Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63: 7563-7570, 2003.
14. Fini L, Selgrad M, Fogliano V, Graziani G, Romano M, Hotchkiss E, Daoud YA, De Vol EB, Boland CR and Ricciardiello L: Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J Nutr: 137: 2622-2628, 2007.
15. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK and Yang CS: Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11: 7033-7041, 2005.
16. Shu L, Khor TO, Lee JH, Boyanapalli SSS, Huang Y, Wu TY, Saw CL, Cheung KL and Kong AN: Epigenetic CpG demeth ylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 13: 606-614, 2011.
17. Yan G, Graham K and Lanza-Jacoby S: Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells. Mol Carcinog Jan 30, 2012 (Epub ahead of print).
18. Lah JJ, Cui W and Hu KQ: Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 13: 5299-5305, 2007.
19. Cui W, Gu F and Hu KQ: Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 15: 1943-1950, 2009.
20. Mateen S, Raina K, Jain A, Agarwal C, Chan D and Agarwal R: Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells. Epigenetics 7: 1161-1172, 2012.
21. Kauntz H, Bousserouel S, Gossé F and Raul F: Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived meta static cells. Apoptosis 16: 1042-1053, 2011.
22. Kauntz H, Bousserouel S, Gossé F, Marescaux J and Raul F: Silibinin, a natural flavonoid, modulates the early expression of chemoprevention biomarkers in a preclinical model of colon carcinogenesis. Int J Oncol 41: 849-854, 2012.